Pyott David E I

Pyott David E I is listed in filings as Director at Alnylam Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Alnylam Pharmaceuticals Inc (ALNY), Tarsus Pharmaceuticals, Inc. (TARS), and Pliant Therapeutics, Inc. (PLRX). The current snapshot covers public activity from Jun 17, 2024 to Jun 3, 2026. Reported amounts are shown as $366.4K to $274.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.